Home/ Supplements/ Electrolytes/ SpectraZyme Metagest

SpectraZyme Metagest

product on market Tablet or Pill Metagenics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for SpectraZyme Metagest
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
45
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1.3 Gram(s)
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Pepsin
90 mg

Other Ingredients

silicified Microcrystalline Cellulose Stearic Acid Cellulose Silica Magnesium Stearate Hypromellose Medium Chain Triglyceride Hydroxypropyl Cellulose
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take two tablets with each meal, or as directed by your healthcare practitioner.

Warnings & Precautions

Caution: If stomach discomfort occurs after administration, discontinue use and consult your healthcare practitioner. Do not use if there is a prior history of or a current peptic or duodenal ulcer.

Consult your healthcare practitioner if pregnant or nursing, or if taking other nutritional supplements or medications.

Keep out of the reach of children.

Formulation Notes

SpectraZyme Metagest features betaine HCI combined with pepsin-a proteolytic enzyme - to complement the natural production of digestive agents in the stomach.

This product is a non-GMO and gluten-free.

Certified gluten free GFCO.org (Gluten-Free Certification Organization)

Stomach acid support

Features betanine HCI & pepsin

Additional Information

Storage: Keep tightly closed in a cool, dry place. Do not refrigerate.

Certified gluten free GFCO.org (Gluten-Free Certification Organization)

Practitioner exclusive

Metadata

Product Details

UPC / SKU7 55571 93965 4
DSLD Entry Date2023-08-23
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
BrandMetagenics
DSLD ID295862
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

Magnesium
Vitabase · Tablet or Pill
100
Natural Magnesium 250 mg
Sunmark · Tablet or Pill
100
Magnesium 250 mg USP
Equaline · Tablet or Pill
100
Magnesium-Oxide
Genesis Products · Tablet or Pill
100
Calcium Pyruvate 750 mg
Martin Avenue Pharmacy · Tablet or Pill
100
View all Electrolytes products →
Electrolytes research Best Electrolytes All Electrolytes products More from Metagenics View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.